Advertisement
Canada markets closed
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7271
    +0.0008 (+0.10%)
     
  • CRUDE OIL

    82.88
    +0.19 (+0.23%)
     
  • Bitcoin CAD

    85,288.34
    -2,590.22 (-2.95%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,389.10
    +0.70 (+0.03%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • NASDAQ futures

    17,731.00
    +72.50 (+0.41%)
     
  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • NIKKEI 225

    38,090.87
    +129.07 (+0.34%)
     
  • CAD/EUR

    0.6807
    +0.0005 (+0.07%)
     

Face the Facts: The CBD Hype Train Has Derailed

Face the Facts: The CBD Hype Train Has Derailed

With tens of billions of dollars in sales being conducted in the black market, it seemed only logical that North America's legal cannabis stocks would benefit after Canada became the first industrialized country in the modern era to legalize adult-use weed, and two-thirds of U.S. states OK'd marijuana use to some varied degree. Since its users won't get buzzed, there was the belief that the market potential for cannabidiol would greatly exceed that of tetrahydrocannabinol (THC)-containing products -- THC being the psychoactive cannabinoid often associated with smoking or consuming marijuana. For those of you keeping score at home, that's a forecasted compound annual growth rate of more than 100%!